Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 17 holding rows worth $53,181,000.

Accession
0000919574-22-006635
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 17 entries on the cover page, a total value of $53,181,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $53,181,000 with VALUE read as thousands by filing date, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
United States Oil Fund LP91232N207COM173,500$11,326,000thousands by filing datecallThe filing omitted confidential holdings, a later amendment may add them.
SAVARA INC805111101COM6,896,551$10,690,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
XERIS BIOPHARMA HOLDINGS INC98422E103COM6,039,028$9,421,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SPY78462F103SHS15,947$5,696,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SCYNEXIS INC811292200COM NEW1,723,947$4,137,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
REZOLUTE INC76200L309COMMON STOCK1,403,157$3,845,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SPDR SER TR78468R556S&P OILGAS EXP17,500$2,183,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MOLECULAR TEMPLATES INC608550109COM2,052,991$1,539,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ARCELLX INC COMMON STOCK03940C100Stock76,186$1,430,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ALPS ETF TR00162Q452ALERIAN MLP29,500$1,079,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
EIGER BIOPHARMACEUTICALS INC28249U105COM116,884$880,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
VECTIVBIO HLDG AGH9060V101COM140,863$845,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ELEVATION ONCOLOGY INC COM28623U101Stock68,297$77,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
FRAZIER LIFESCIENCES ACQU COG3710A113WTS21,333$17,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
LUX HEALTH TECH ACQUISITION55068A118*W EXP 11/30/20266,666$9,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
BRIDGETOWN HOLDINGS LTDG1355U121*W EXP 09/30/20239,773$5,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
PRIMAVERA CAPITAL ACQUIST COG7255E117WTS12,000$2,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-22-006635this filing2022-11-14acceptance time not in the bulk data set